• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者左心室舒张功能障碍的病例队列研究:肝-心轴

A case-cohort study of left ventricular diastolic dysfunction in patients with cirrhosis: the liver-heart axis.

作者信息

Solanki Rushil, Sreesh Srijaya, Attumalil Thomas Varghese, Mohapatra Shivabrata Dhal, Narayanan Vijay, Madhu Devika, Chakravorty Avisek, Pal Ravindra, Nair Anjana Nalina Kumari Kesavan, Devadas Krishnadas

机构信息

Department of Gastroenterology, Government Medical College, Thiruvananthapuram, Kerala (Rushil Solanki, Srijaya Sreesh, Shivabrata dhal Mohapatra, Vijay Narayanan, Devika Madhu, Avisek Chakravorty, Ravindra Pal, Krishnadas Devadas).

Department of Cardiology, CMC Vellore (Thomas Varghese Attumalil).

出版信息

Ann Gastroenterol. 2023 Nov-Dec;36(6):678-685. doi: 10.20524/aog.2023.0837. Epub 2023 Oct 30.

DOI:10.20524/aog.2023.0837
PMID:38023969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10662073/
Abstract

BACKGROUND

Left ventricular diastolic dysfunction (LVDD) is an early manifestation of cirrhotic cardiomyopathy. Few studies have addressed its clinical significance in cirrhosis. We assessed the association of LVDD with the factors affecting cirrhosis patients' severity, complications, and survival.

METHODS

A total of 203 cirrhosis patients were enrolled and underwent investigations, including 2-dimensional echocardiography with tissue Doppler imaging, and 139 patients with LVDD (cases) were compared with 64 patients without LVDD (controls). Logistic regression and Kaplan-Meier analysis were applied.

RESULTS

Mean age was 52.76±10 years. Among LVDD patients, 56% had grade-1, and 44% had grade-2 LVDD. Cirrhosis related to NASH had a more significant association with LVDD (P<0.001) than other etiologies. LVDD was significantly associated with a greater incidence of Child-Turcotte-Pugh (CTP) class C (P<0.001), higher model for end-stage liver disease scores (P=0.001), duration of cirrhosis >2 years since diagnosis (P=0.028), ascites (P<0.001), hepatic encephalopathy (P<0.010), hepatorenal syndrome (P<0.001), and a history of obesity (P=0.004). Multivariate analysis showed that higher CTP score, ascitic fluid protein and prolonged QTc interval were independently associated with LVDD (P=0.009; P=0.018; P=0.016, respectively). Kaplan-Meier survival analysis showed significantly poorer survival status in patients with higher grades of LVDD (P<0.001). The area under the receiver operating characteristic curve (0.78) was greatest for ascitic fluid protein in predicting LVDD, with a cutoff of >1 g/dL.

CONCLUSIONS

Higher CTP score, prolonged QTc, higher ascitic fluid protein levels, and poor survival are significantly associated with LVDD. Ascitic fluid protein >1 g/dL could be an indicator for evaluating LVDD.

摘要

背景

左心室舒张功能障碍(LVDD)是肝硬化性心肌病的早期表现。很少有研究探讨其在肝硬化中的临床意义。我们评估了LVDD与影响肝硬化患者病情严重程度、并发症及生存的因素之间的关联。

方法

共纳入203例肝硬化患者并进行相关检查,包括二维超声心动图及组织多普勒成像,将139例LVDD患者(病例组)与64例无LVDD患者(对照组)进行比较。应用逻辑回归和Kaplan-Meier分析。

结果

平均年龄为52.76±10岁。在LVDD患者中,56%为1级,44%为2级LVDD。与非酒精性脂肪性肝炎(NASH)相关的肝硬化与LVDD的关联比其他病因更显著(P<0.001)。LVDD与Child-Turcotte-Pugh(CTP)分级C级的发生率更高显著相关(P<0.001),终末期肝病模型评分更高(P=0.001),诊断后肝硬化病程>2年(P=0.028),腹水(P<0.001),肝性脑病(P<0.010),肝肾综合征(P<0.001)以及肥胖史(P=0.004)相关。多因素分析显示,较高的CTP评分、腹水蛋白及延长的QTc间期与LVDD独立相关(分别为P=0.009;P=0.018;P=0.016)。Kaplan-Meier生存分析显示,LVDD分级较高的患者生存状况明显较差(P<0.001)。在预测LVDD方面,腹水蛋白的受试者工作特征曲线下面积(0.78)最大,临界值>1 g/dL。

结论

较高的CTP评分、延长的QTc、较高的腹水蛋白水平及较差的生存与LVDD显著相关。腹水蛋白>1 g/dL可作为评估LVDD的一个指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/10662073/8cf55275739b/AnnGastroenterol-36-678-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/10662073/48b2d8047976/AnnGastroenterol-36-678-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/10662073/8cf55275739b/AnnGastroenterol-36-678-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/10662073/48b2d8047976/AnnGastroenterol-36-678-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee85/10662073/8cf55275739b/AnnGastroenterol-36-678-g006.jpg

相似文献

1
A case-cohort study of left ventricular diastolic dysfunction in patients with cirrhosis: the liver-heart axis.肝硬化患者左心室舒张功能障碍的病例队列研究:肝-心轴
Ann Gastroenterol. 2023 Nov-Dec;36(6):678-685. doi: 10.20524/aog.2023.0837. Epub 2023 Oct 30.
2
Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.左心室舒张功能障碍与肝硬化患者的肾功能不全、生存率低及健康相关生活质量差有关。
J Clin Exp Hepatol. 2019 May-Jun;9(3):324-333. doi: 10.1016/j.jceh.2018.08.008. Epub 2018 Aug 30.
3
Diagnosis and Management of Cirrhotic Cardiomyopathy.肝硬化性心肌病的诊断与管理
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):186-199. doi: 10.1016/j.jceh.2021.08.016. Epub 2021 Aug 21.
4
Evaluating Diastolic Dysfunction as an Indicator of Cirrhotic Cardiomyopathy in Decompensated Chronic Liver Disease.评估舒张功能障碍作为失代偿期慢性肝病中肝硬化心肌病指标的作用
Cureus. 2024 Jun 28;16(6):e63388. doi: 10.7759/cureus.63388. eCollection 2024 Jun.
5
Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis.舒张性心功能不全是肝硬化患者预后不良的一个预测指标。
Hepatol Int. 2014 Oct;8(4):588-94. doi: 10.1007/s12072-014-9544-6. Epub 2014 Jun 8.
6
Factors Predicting Cardiac Dysfunction in Patients with Liver Cirrhosis.肝硬化患者心脏功能障碍的预测因素
Middle East J Dig Dis. 2021 Jul;13(3):216-222. doi: 10.34172/mejdd.2021.228. Epub 2021 Mar 23.
7
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites.肝硬化伴腹水患者左心室舒张功能障碍与炎症活动、肾功能障碍和肝相关死亡率的关系。
Eur J Gastroenterol Hepatol. 2024 Jun 1;36(6):775-783. doi: 10.1097/MEG.0000000000002762. Epub 2024 Mar 19.
8
Impact of left ventricular diastolic dysfunction on liver transplantation outcomes based on the latest American Society of Echocardiography/European Association of Cardiovascular Imaging recommendations.基于美国超声心动图学会/欧洲心血管影像学会最新建议,探讨左心室舒张功能障碍对肝移植结局的影响。
Clin Exp Hepatol. 2021 Dec;7(4):390-395. doi: 10.5114/ceh.2021.111001. Epub 2021 Nov 26.
9
Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis.心脏舒张功能障碍可预测失代偿期肝硬化患者的预后不良。
Clin Mol Hepatol. 2018 Dec;24(4):409-416. doi: 10.3350/cmh.2018.0034. Epub 2018 Aug 27.
10
Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine.舒张功能障碍是肝硬化、门静脉高压和肌酐正常患者预后不良的预测指标。
Hepatology. 2013 Nov;58(5):1732-41. doi: 10.1002/hep.26509. Epub 2013 Sep 30.

引用本文的文献

1
The Assessment of Cardiovascular Abnormalities in Patients With Chronic Liver Disease: A Cross-Sectional Study.慢性肝病患者心血管异常的评估:一项横断面研究。
Cureus. 2024 Nov 9;16(11):e73311. doi: 10.7759/cureus.73311. eCollection 2024 Nov.
2
The Interplay between Severe Cirrhosis and Heart: A Focus on Diastolic Dysfunction.重度肝硬化与心脏之间的相互作用:聚焦舒张功能障碍
J Clin Med. 2024 Sep 13;13(18):5442. doi: 10.3390/jcm13185442.

本文引用的文献

1
Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis.舒张功能障碍是失代偿期肝硬化患者生存预后不良的一个预测指标。
Int J Hepatol. 2021 Dec 2;2021:5592376. doi: 10.1155/2021/5592376. eCollection 2021.
2
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction.非酒精性脂肪性肝病与射血分数保留的心力衰竭之间的关系
JACC Basic Transl Sci. 2021 Nov 22;6(11):918-932. doi: 10.1016/j.jacbts.2021.07.010. eCollection 2021 Nov.
3
Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.
左心室舒张功能障碍与肝硬化患者的肾功能不全、生存率低及健康相关生活质量差有关。
J Clin Exp Hepatol. 2019 May-Jun;9(3):324-333. doi: 10.1016/j.jceh.2018.08.008. Epub 2018 Aug 30.
4
Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis.心脏舒张功能障碍可预测失代偿期肝硬化患者的预后不良。
Clin Mol Hepatol. 2018 Dec;24(4):409-416. doi: 10.3350/cmh.2018.0034. Epub 2018 Aug 27.
5
New Definition Criteria of Myocardial Dysfunction in Patients with Liver Cirrhosis: A Speckle Tracking and Tissue Doppler Imaging Study.肝硬化患者心肌功能障碍的新定义标准:一项斑点追踪和组织多普勒成像研究。
Ultrasound Med Biol. 2018 Mar;44(3):562-574. doi: 10.1016/j.ultrasmedbio.2017.11.013. Epub 2018 Jan 3.
6
Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?肝硬化性心肌病:心脏损害程度与肝脏疾病严重程度之间是否存在关联?
Libyan J Med. 2017 Dec;12(1):1283162. doi: 10.1080/19932820.2017.1283162.
7
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications.非酒精性脂肪性肝病与心血管风险:病理生理机制及意义。
J Hepatol. 2016 Aug;65(2):425-43. doi: 10.1016/j.jhep.2016.04.005. Epub 2016 Jun 1.
8
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.超声心动图评估左心室舒张功能的建议:美国超声心动图学会和欧洲心血管影像学会的更新
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314. doi: 10.1016/j.echo.2016.01.011.
9
Cirrhotic cardiomyopathy.肝硬化性心肌病
World J Gastroenterol. 2015 Nov 7;21(41):11502-21. doi: 10.3748/wjg.v21.i41.11502.
10
Diastolic dysfunction diagnosed by tissue Doppler imaging in cirrhotic patients: Prevalence and its possible relationship with clinical outcome.组织多普勒成像诊断肝硬化患者舒张功能障碍:患病率及其与临床结局的可能关系。
Eur J Intern Med. 2015 Dec;26(10):830-4. doi: 10.1016/j.ejim.2015.10.009. Epub 2015 Oct 29.